High-content screening is a powerful technology platform for implementing functional cell-based assays that allow truly multi-parametric analysis in the physiological context of intact cells. This course provides an introductory level overview of the state-of-the-art components of HCS together with some showcases of high-content screens in industry and academia.

Eberhard Krausz

Expert ScientistVIB - Discovery Sciences

Eberhard Krausz is working for VIB, a more than 1500 scientists counting life science research organisation located in Flanders, Belgium, translating basic research outcomes into industrial applications. Since 2008, he has been supporting scientists during various positions in industry and academia in technology selection, target identification & validation, assay development & screening, and drug discovery. In 2003-2008, he was heading the central high-content screening labs at the Max Planck Institute in Dresden, Germany. Before, he held responsible positions in biotech industry at Cenix BioScience (Germany) and Cyclacel (Scotland, UK) dealing with RNA interference (RNAi) and drug discovery, respectively.
Eberhard Krausz was for many years member of the Academic Outreach Committee (AOC) of the Society of Biomolecular Screening, now SLAS. He served twice the Steering Committee of the Joint Working Group ‘Chemical Biology’ of Dechema, GBM, GDCh and DPhG in Germany.